Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026)

DiaMedica Therapeutics filings provide 10 years of Prepaid Assets readings, the most recent being $731000.0 for Q1 2026.

  • Quarterly Prepaid Assets rose 12.63% to $731000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $731000.0 through Mar 2026, up 12.63% year-over-year, with the annual reading at $481000.0 for FY2025, 111.89% up from the prior year.
  • Prepaid Assets hit $731000.0 in Q1 2026 for DiaMedica Therapeutics, up from $481000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $962000.0 in Q1 2023 and bottomed at $209000.0 in Q4 2022.
  • Average Prepaid Assets over 5 years is $521941.2, with a median of $534000.0 recorded in 2022.
  • The largest annual shift saw Prepaid Assets plummeted 44.77% in 2024 before it soared 111.89% in 2025.
  • DiaMedica Therapeutics' Prepaid Assets stood at $209000.0 in 2022, then surged by 96.65% to $411000.0 in 2023, then plummeted by 44.77% to $227000.0 in 2024, then skyrocketed by 111.89% to $481000.0 in 2025, then surged by 51.98% to $731000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Prepaid Assets are $731000.0 (Q1 2026), $481000.0 (Q4 2025), and $445000.0 (Q3 2025).